Home Newsfeeds Morgan Stanley Maintains Overweight on AbbVie, Lowers Price Target to $188

Morgan Stanley Maintains Overweight on AbbVie, Lowers Price Target to $188

Morgan Stanley analyst Matthew Harrison maintains AbbVie (NYSE:ABBV) with a Overweight and lowers the price target from $191 to $188.

byBenzinga Newsdesk

August 1, 2022

1 minute read

Morgan Stanley analyst Matthew Harrison maintains AbbVie (NYSE:ABBV) with a Overweight and lowers the price target from $191 to $188.

Ocwen Financial President And CEO Glen Messina Appointed As Board Chair

By Benzinga Newsdesk

January 23, 5:18 PM

Ocwen Financial Corporation (NYSE:OCN) ("Ocwen" or the "Company"), a leading non-bank mortgage servicer and originator, today announced that its Board of Directors (the "Board") has

OCN

Citigroup Maintains Neutral on CSX, Lowers Price Target to $30

By Benzinga Newsdesk

September 29, 7:43 AM

Citigroup analyst Christian Wetherbee maintains CSX (NASDAQ:CSX) with a Neutral and lowers the price target from $31 to $30.

CSX

Weed-Focused Tech Company Reports Positive Adjusted EBITDA In Q2, What About Net Income?

By Nina Zdinjak

August 9, 8:55 AM

Cannabis-focused tech company WM Technology, Inc. (NASDAQ: MAPS) released its financial results for the second quarter ended June 30, 2023, disclosing revenue of $50.9 million, compared to $48.0 million in the previous quarter and $58.3 million in the same period last year.

MAPS

Akerna Reports Halloween Weekend Cannabis Sales Total $249.6M

By Benzinga Newsdesk

November 3, 3:58 PM

Akerna (NASDAQ:KERN), a leading enterprise software company and the developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today

KERN

Morgan Stanley Maintains Overweight on AbbVie, Lowers Price Target to $188

Related Posts

Ocwen Financial President And CEO Glen Messina Appointed As Board Chair

Citigroup Maintains Neutral on CSX, Lowers Price Target to $30

Weed-Focused Tech Company Reports Positive Adjusted EBITDA In Q2, What About Net Income?

Akerna Reports Halloween Weekend Cannabis Sales Total $249.6M